KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Equity Average (2016 - 2025)

Historic Equity Average for Biolife Solutions (BLFS) over the last 15 years, with Q3 2025 value amounting to $350.4 million.

  • Biolife Solutions' Equity Average rose 834.61% to $350.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $350.4 million, marking a year-over-year increase of 834.61%. This contributed to the annual value of $343.3 million for FY2024, which is 217.7% down from last year.
  • Per Biolife Solutions' latest filing, its Equity Average stood at $350.4 million for Q3 2025, which was up 834.61% from $349.9 million recorded in Q2 2025.
  • Over the past 5 years, Biolife Solutions' Equity Average peaked at $483.7 million during Q4 2021, and registered a low of $206.6 million during Q1 2021.
  • For the 5-year period, Biolife Solutions' Equity Average averaged around $366.9 million, with its median value being $350.4 million (2025).
  • As far as peak fluctuations go, Biolife Solutions' Equity Average soared by 28089.91% in 2021, and later crashed by 2429.74% in 2023.
  • Biolife Solutions' Equity Average (Quarter) stood at $483.7 million in 2021, then dropped by 20.47% to $384.7 million in 2022, then dropped by 12.95% to $334.8 million in 2023, then increased by 0.7% to $337.2 million in 2024, then rose by 3.93% to $350.4 million in 2025.
  • Its Equity Average was $350.4 million in Q3 2025, compared to $349.9 million in Q2 2025 and $350.8 million in Q1 2025.